Douglas Scott Wieland
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John Caloz | M | 72 | 17 years | |
Felix Kratz | M | - | 10 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Linda Baddour | F | 65 | 11 years | |
Joseph Rubinfeld | M | 91 | 14 years | |
Max E. Link | M | 84 | 18 years | |
Earl Warren Brien | M | 64 | 5 years | |
Anita J. Chawla | M | 65 | 2 years | |
Patrick Spine | M | 61 | 6 years | |
Christopher Gaenzle | M | 57 | 2 years | |
Eric Jay Selter | M | 66 | 2 years | |
Max Lin | M | 43 | 6 years | |
David W. Dockhorn | M | 63 | 21 years | |
Alexander Dickinson | M | 62 | 4 years | |
Marvin R. Selter | M | 95 | 11 years | |
Daniel J. Levitt | M | 76 | 8 years | |
Cheryl Cohen | F | 58 | 1 years | |
Benjamin S. Levin | M | 46 | 12 years | |
David A. H. Lee | M | 74 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 5 years |
Kimberly E. Vanover | M | 58 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 5 years |
Laurie Duffy Hurst | F | - | 3 years | |
Olivia Ware | F | 67 | 1 years | |
Mark A. Tepper | M | 49 | - | |
Timothy J. McClain | M | - | 10 years | |
Christine Rogers | F | - | 4 years | |
Shanta P. Chawla | M | 76 | 3 years | |
Shi-Chung Ng | M | 69 | - | |
Matthew Natalizio | M | 69 | 3 years | |
Mitchell K. Fogelman | M | 72 | 1 years | |
James H. Coleman | M | 82 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | - |
David Brian Fick | M | - |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 7 years |
Roger Boutin | M | - | 14 years | |
David Scott Geyer | M | 65 | - | |
Edward P. Monaghan | M | - |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | - |
Ali Satvat | M | 46 | 5 years | |
Lowell E. Sears | M | 73 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 4 years |
Jaisim Shah | M | 63 | - | |
Michael Brooks | M | 50 | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 37 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Douglas Scott Wieland
- Personal Network